Kwality Pharmaceuticals Q2 Results Live: Profit Rises by 35.83% YoY

Kwality Pharmaceuticals Q2 Results Live : Kwality Pharmaceuticals declared their Q2 results on 30 Oct, 2024, showcasing a remarkable performance with the topline increasing by 29.27% year-over-year, while profit surged by 35.83% compared to the same quarter last year.

In comparison to the previous quarter, the company reported a revenue growth of 12.43% and a profit increase of 1.36%, indicating consistent upward momentum.

However, the company faced rising Selling, General & Administrative expenses, which climbed by 5.96% quarter-over-quarter and saw a significant increase of 30.04% year-over-year, reflecting higher operational costs.

Despite the increase in expenses, Kwality Pharmaceuticals reported a robust operating income growth of 12.91% quarter-over-quarter and an impressive 45.35% year-over-year, signaling strong operational efficiency.

The Earnings Per Share (EPS) for Q2 stood at ₹8.15, marking a 36.06% increase year-over-year, further highlighting the company's profitability growth.

In terms of market performance, Kwality Pharmaceuticals has delivered an impressive 18.93% return in the last week, a staggering 86.7% in the last six months, and an astonishing 133.09% return year-to-date.

Currently, Kwality Pharmaceuticals has a market capitalization of ₹966.96 Crores, with its stock trading between a 52-week high of ₹944.8 and a low of ₹320, reflecting significant investor confidence.